McKesson (MCK) declares $0.82/share quarterly dividend, in line with previous. Forward yield 0.41% Payable Jan. 2; for ...

McKesson is expected to announce its second-quarter results next month, and analysts predict a double-digit increase in the ...

While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. One imperfect but simple way to consider how the market perception of ...

McKesson (MCK) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

McKesson Corp. closed 3.08% below its 52-week high of $846.32, which the company reached on October 30th.

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its first quarter fiscal 2025 financial results after market close on Wednesday, August 7, 2024. The company will host a ...

McKesson Corporation (NYSE:MCK) is one of the 11 Best Drug Stocks to Buy According to Hedge Funds. On June 11, analyst Michael Cherny of Leerink Partners maintained a Buy rating on McKesson ...

San Francisco-based McKesson Corp., a retail pharmaceutical distributor that also provides health information technology, medical supplies, and care management tools, recently opened a new campus in ...

IRVING, Texas--(BUSINESS WIRE)--The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of $0.82 per share of common stock, a 15% increase from $0.71 per share ...

Count yourself lucky if you were a McKesson Corporation (NYSE: MCK) investor this year. While most of the stocks have fallen steeply, McKesson has grown more than 10%, increasing from $139 to $153 (as ...

McKesson Corp has appointed Tracy Faber to executive vice president and chief human resources officer, which will take effect in October. She will report to McKesson’s new CEO Brian Tyler. Faber has ...

New York state prosecutors have served the McKesson Corp. with a subpoena in connection with a multistate investigation into the San Francisco-based drug distribution giant’s opioid marketing and ...